STOCK TITAN

Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Omnicell, Inc. (OMCL) is set to release its financial results for the fourth quarter and full year 2023 on February 8, 2024. The company will host a conference call and webcast to discuss the results. Interested parties can listen to the live call and presentation or access the archived webcast through the Investor Relations section of Omnicell’s website.
Positive
  • None.
Negative
  • None.

FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.

All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. The Conference ID is 9581556. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/.

About Omnicell

Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.

OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.

OMCL-E

Kathleen Nemeth

Senior Vice President, Investor Relations

ir@omnicell.com

Source: Omnicell, Inc.

FAQ

When will Omnicell, Inc. release its financial results for the fourth quarter and full year 2023?

Omnicell, Inc. (OMCL) will release its financial results on Thursday, February 8, 2024, before market open.

How can I access the conference call and webcast to discuss Omnicell's financial results?

Interested parties can listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. The Conference ID is 9581556. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/.

Omnicell Inc

NASDAQ:OMCL

OMCL Rankings

OMCL Latest News

OMCL Stock Data

1.38B
45.23M
1.47%
101.18%
5.06%
Electronic Computer Manufacturing
Manufacturing
Link
United States of America
FORT WORTH

About OMCL

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice